Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Chamberlain

Showing results (131-140 of 133) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 133 results.
Blood Cancer Discovery|May 24, 2021
Avadomide induces degradation of ZMYM2 fusion oncoproteins in hematologic malignanciesAline Renneville, Jessica A Gasser, Daniel E Grinshpun, et al.
Journal of Medicinal Chemistry|October 7, 2025
Discovery of Potent and Selective BCL6 Ligand-Directed Degrader (LDD), BCL6-760Hunter P Shunatona, Natalie Holmberg Douglas, Jayce Rhodes, et al.
Journal of Medicinal Chemistry|October 10, 2017
The Discovery of a Dual TTK Protein Kinase/CDC2-Like Kinase (CLK2) Inhibitor for the Treatment of Triple Negative Breast Cancer Initiated from a Phenotypic ScreenJennifer R Riggs, Mark Nagy, Jan Elsner, et al.
Pageof 14

Showing results (131-140 of 133) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 133 results.
Blood Cancer Discovery|May 24, 2021
Avadomide induces degradation of ZMYM2 fusion oncoproteins in hematologic malignanciesAline Renneville, Jessica A Gasser, Daniel E Grinshpun, et al.
Journal of Medicinal Chemistry|October 7, 2025
Discovery of Potent and Selective BCL6 Ligand-Directed Degrader (LDD), BCL6-760Hunter P Shunatona, Natalie Holmberg Douglas, Jayce Rhodes, et al.
Journal of Medicinal Chemistry|October 10, 2017
The Discovery of a Dual TTK Protein Kinase/CDC2-Like Kinase (CLK2) Inhibitor for the Treatment of Triple Negative Breast Cancer Initiated from a Phenotypic ScreenJennifer R Riggs, Mark Nagy, Jan Elsner, et al.
Pageof 14